![Marc Schegerin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Schegerin
Direttore Finanziario/CFO presso
MORC HOLD
Profilo
Marc Schegerin is Chief Executive Officer at Talawar Tx, Inc. since 2026.
Since 2020, serves as Independent Director at SQZ Biotechnologies Co. Also since 2020, holds the positions of Chief Financial & Operating Officer at Morphic Therapeutic, Inc. and Chief Operating & Financial Officer at Morphic Holding, Inc. Formerly Program Director at Biogen, Inc. from 2009 to 2013.
Served as Senior Director at SAGE Therapeutics, Inc. from 2013 to 2014.
Worked as Director at Citigroup, Inc. from 2016 to 2018.
Held the role of Chief Financial Officer, Treasurer & Head-Strategy at ArQule, Inc. from 2019 to 2020.
Education includes undergraduate studies at Tulane University (Louisiana) and Harvard University, a doctorate from Dartmouth Medical School, and an MBA from Tuck School of Business at Dartmouth.
Posizioni attive di Marc Schegerin
| Società | Posizione | Inizio |
|---|---|---|
| MORC HOLD | Direttore Finanziario/CFO | 06/04/2020 |
| SQZ BIOTECHNOLOGIES COMPANY | Direttore/Membro del Consiglio | 23/10/2020 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Direttore Finanziario/CFO | 01/04/2020 |
Precedenti posizioni note di Marc Schegerin
| Società | Posizione | Fine |
|---|---|---|
| ARQULE, INC. | Direttore Finanziario/CFO | 01/01/2020 |
| CITIGROUP INC. | Direttore/Membro del Consiglio | 01/04/2018 |
| SAGE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2014 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2013 |
Formazione di Marc Schegerin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
 Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
